Integra LifeSciences Holdings (IART) financials · rev $1.64B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Integra LifeSciences Holdings (IART) rev $1.64B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.64B | $1.61B |
| Cost of Revenue | $803.6M | $728.5M |
| Gross Profit | $831.6M | $882.1M |
| Operating Income | -$493.4M | $28.4M |
| Net Income | -$516.5M | -$6.94M |
| EPS (Diluted) | -$6.74 | -$0.09 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $3.60B | $4.04B |
| Current Assets | $1.16B | $1.08B |
| Cash & Equivalents | $235.0M | $246.4M |
| Inventory | $492.7M | $429.1M |
| PP&E | $444.3M | $405.7M |
| Total Liabilities | $2.56B | $2.49B |
| Current Liabilities | $456.0M | $922.1M |
| Long-term Debt | $726.6M | $760.5M |
| Total Debt | $726.6M† | $760.5M† |
| Shareholders' Equity | $1.04B | $1.55B |
| Retained Earnings | $423.4M | $939.9M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $50.4M | $129.4M |
| CapEx | $81.4M | $104.4M |
| Investing Cash Flow | -$108.1M | -$390.8M |
| Financing Cash Flow | $28.3M | $237.9M |
| Net Change in Cash | -$11.3M | -$30.0M |
| Free Cash Flow | -$31.1M | $25.0M |
FAQ
What is IART P/E and revenue?
Integra LifeSciences Holdings (IART) rev $1.64B.
What is IART revenue?
Integra LifeSciences Holdings last cached revenue is $1.64B (FY2025).
Is IART profitable?
Integra LifeSciences Holdings last cached net income is -$516.5M (FY2025).
What are IART total assets?
Integra LifeSciences Holdings last cached total assets are $3.60B (FY2025).
What is IART free cash flow?
Integra LifeSciences Holdings last cached free cash flow is -$31.1M (FY2025).
Not investment advice. Cached statements, not a live tape.